ZA804680B - Pharmaceutical compositions for the prevention of tumour metastasis - Google Patents

Pharmaceutical compositions for the prevention of tumour metastasis

Info

Publication number
ZA804680B
ZA804680B ZA00804680A ZA804680A ZA804680B ZA 804680 B ZA804680 B ZA 804680B ZA 00804680 A ZA00804680 A ZA 00804680A ZA 804680 A ZA804680 A ZA 804680A ZA 804680 B ZA804680 B ZA 804680B
Authority
ZA
South Africa
Prior art keywords
prevention
pharmaceutical compositions
tumour metastasis
tumour
metastasis
Prior art date
Application number
ZA00804680A
Other languages
English (en)
Inventor
E Mueller
J Nickl
J Roch
B Narr
W Haarmann
J Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of ZA804680B publication Critical patent/ZA804680B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA00804680A 1979-08-04 1980-08-01 Pharmaceutical compositions for the prevention of tumour metastasis ZA804680B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792931741 DE2931741A1 (de) 1979-08-04 1979-08-04 Arzneimittel zur vermeidung von tumormetastierung

Publications (1)

Publication Number Publication Date
ZA804680B true ZA804680B (en) 1982-04-28

Family

ID=6077677

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00804680A ZA804680B (en) 1979-08-04 1980-08-01 Pharmaceutical compositions for the prevention of tumour metastasis

Country Status (7)

Country Link
JP (1) JPS5636452A (fr)
AU (1) AU539070B2 (fr)
BE (1) BE884628A (fr)
DE (1) DE2931741A1 (fr)
IT (1) IT1212438B (fr)
NZ (1) NZ194531A (fr)
ZA (1) ZA804680B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2121148A1 (fr) * 1992-08-19 1994-03-03 Otsuka Pharmaceutical Co., Ltd. Regulateur de l'apoptose
US5635514A (en) * 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors

Also Published As

Publication number Publication date
AU6100680A (en) 1981-02-12
NZ194531A (en) 1984-08-24
AU539070B2 (en) 1984-09-13
JPS5636452A (en) 1981-04-09
BE884628A (fr) 1981-02-04
DE2931741A1 (de) 1981-02-26
IT8023121A0 (it) 1980-06-30
IT1212438B (it) 1989-11-22

Similar Documents

Publication Publication Date Title
GB2050828B (en) Process for the preparations of finely divided pharmaceutical compositions
PT67009A (en) Processes for the preparation of pharmaceutical compositions
GB1542848A (en) Anti-mycotic pharmaceutical compositions containing enzymes
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
PH16443A (en) Substituted tetraazetricyclic compounds and their pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
ZA805666B (en) Pharmaceutical compositions containing paracetamol
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
IL59836A0 (en) Pharmaceutical oxytetracycline compositions
GB2072504B (en) Pharmaceutical compositions
IL61117A0 (en) Acetoxymethyl-penem compounds and pharmaceutical compositions containing them
GB2053230B (en) Tripeptides of the general formula
IL57476A0 (en) Compounds of the muramy-peptide type and pharmaceutical compositions containing them
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
PT71537A (en) Compositions of matter
ZA815700B (en) Pharmaceutical compositions
DE3064666D1 (en) Pharmaceutical compositions containing paracetamol
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
PT72237A (en) Process for the preparation of new pyrrolbenzotriazepines having pharmaceutical effect
ZA804680B (en) Pharmaceutical compositions for the prevention of tumour metastasis
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
IL60600A (en) Pharmaceutical compositions comprising certain azolylalkenol compounds
PT71885A (en) Process for the preparation of ergot-peptide alkaloides having pharmaceutical effect
ZA817684B (en) Pharmaceutical compositions